Victor M Moyo
Overview
Explore the profile of Victor M Moyo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moyo V, Mvundura E, Khumalo H, Gangaidzo I, Saungweme T, Nouraie M, et al.
Ann Hematol
. 2009 Mar;
88(11):1131-6.
PMID: 19259672
In the setting of high dietary, several studies have provided evidence for a strong effect of both high dietary iron and an unidentified genetic locus on iron stores in Africans....
2.
Moyo V, Mukhina G, Garrett E, Brodsky R
Br J Haematol
. 2004 Jun;
126(1):133-8.
PMID: 15198744
Paroxysmal nocturnal haemoglobinuria (PNH) is an uncommon, acquired disorder of blood cells caused by mutation of the phosphatidylinositol glycan class A (PIG-A) gene. The disease often manifests with haemoglobinuria, peripheral...
3.
Gordeuk V, Caleffi A, Corradini E, Ferrara F, Jones R, Castro O, et al.
Blood Cells Mol Dis
. 2003 Nov;
31(3):299-304.
PMID: 14636642
The product of the SLC40A1 gene, ferroportin 1, is a main iron export protein. Pathogenic mutations in ferroportin 1 lead to an autosomal dominant hereditary iron overload syndrome characterized by...
4.
5.
Kasvosve I, Gordeuk V, Delanghe J, Gomo Z, Gangaidzo I, Khumalo H, et al.
Clin Chem Lab Med
. 2002 Oct;
40(8):810-3.
PMID: 12392310
Iron status in man is influenced by environmental and genetic factors. The molecular variation of haptoglobin is one of the genetic factors influencing iron status in Caucasians. Differences in iron...
6.
Moyo V, Smith D, Brodsky I, Crilley P, Jones R, Brodsky R
Blood
. 2002 Jul;
100(2):704-6.
PMID: 12091370
High-dose cyclophosphamide, without stem cell rescue, has been used successfully to treat aplastic anemia and other autoimmune disorders. To determine the safety and efficacy of high-dose cyclophosphamide among patients with...
7.
Kasvosve I, Delanghe J, Gomo Z, Gangaidzo I, Khumalo H, Langlois M, et al.
Am J Clin Nutr
. 2002 Jan;
75(2):321-5.
PMID: 11815325
Background: Transferrin is the major iron binding protein in human plasma. In black persons, the transferrin CD phenotype has been associated with alterations in certain markers of iron status. Objective:...